4 Apr 2008 14:38
e-Therapeutics plc04 April 2008 e-Therapeutics plc (the "Company") Director's Holding in the Company The Company was notified on 4 April 2008 that the partner of John Cordiner,Commercial and Finance Director, acquired 9,190 ordinary shares of 0.1 penceeach in the capital of the Company ("Ordinary Shares") on 2 April 2008 at aprice of 54 pence per Ordinary Share. The Company was also notified on 4 April 2008 that John Cordiner acquired 8,000Ordinary Shares on 2 April 2008 at a price of 58 pence per Ordinary Share.Following these acquisitions, John Cordiner has a total notifiable interest of371,250 Ordinary Shares, representing 0.67% of the issued share capital of theCompany. For further information, please contact: e-Therapeutics plcJohn Cordiner 0191 233 1317 WH Ireland LimitedRichard Lindley 0113 394 6628 This information is provided by RNS The company news service from the London Stock Exchange
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
ETX.L Regulatory News (ETX)
ETX Share
Price
ETX Share
News
ETX Share
Chat
ETX Share
Trades
ETX
Live RNS
ETX Share
Charts
ETX Broker
Ratings
ETX Directors
Deals
ETX Financial
Diary
ETX
Fundamentals
ETX Short
Positions
ETX
Media
ETX.L Information
- There is currently no data for ETX
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.Director/PDMR Shareholding
| Date | Source | Headline | |
|---|---|---|---|
| 10th Oct 2008 | 12:30 pm | RNS | Positive PhaseIIa trial of oral asthma drug |
| 8th Oct 2008 | 7:00 am | RNS | Interim Results |
| 15th Sep 2008 | 7:00 am | RNS | e-Therapeutics partners with KeyGen Biotechnology |
| 4th Sep 2008 | 4:35 pm | RNS | Directorate Change |
| 21st Jul 2008 | 3:42 pm | RNS | Final Results |
| 6th May 2008 | 7:03 am | RNS | Launch of Consultancy Service |
| 4th Apr 2008 | 2:38 pm | RNS | Director/PDMR Shareholding |
| 5th Feb 2008 | 12:02 pm | RNS | Holding(s) in Company |
| 22nd Jan 2008 | 7:01 am | RNS | ETS2101 preclinical progress |
| 10th Dec 2007 | 11:18 am | RNS | Preclinical Update |
| 3rd Dec 2007 | 4:58 pm | RNS | Director/PDMR Shareholding |
| 28th Nov 2007 | 8:00 am | RNS | First day of dealings on AIM |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.